MS-N152 · Dietary pattern · Immunotherapy · Melanoma · Prospective observational evidence · Appraised 27 October 2026

Is higher food-derived fiber intake associated with better outcomes during immune-checkpoint blockade for advanced melanoma?

Evidence at a glance

• Evidence label: Encouraging association; not an intervention trial
• Benefit: Among 128 patients, higher fiber intake was associated with longer progression-free survival, especially without probiotic-supplement use.
• Certainty: Low for causality. Diet was not randomized, and healthier diet, microbiome, fitness and socioeconomic factors may confound the association.
• Risk: Abruptly increasing fiber can worsen bloating, diarrhea, constipation or obstruction risk; immunotherapy colitis requires medical assessment, not self-treatment with fiber.

What was studied

A prospective cohort assessed diet, commercial probiotic use and fecal microbiota in patients with melanoma starting immune-checkpoint blockade. Progression-free survival analyses included 128 patients; parallel mouse experiments explored mechanisms.

What the evidence found

Higher dietary fiber was associated with significantly improved progression-free survival. The strongest association appeared in people reporting sufficient fiber and no probiotic supplement. The human study did not randomly assign fiber or probiotics; mouse experiments cannot establish patient benefit.

How to interpret it

This is a credible research signal supporting prospective trials, not proof that adding a fiber supplement makes immunotherapy work better. Food-derived fiber, a specific supplement and probiotic capsules are different exposures.

Practical safety context

Discuss changes with the oncology team if there is active colitis, severe diarrhea, bowel narrowing, recent bowel surgery, ostomy problems or poor hydration. Fever, blood in stool, persistent pain or frequent diarrhea during immunotherapy needs prompt assessment.

Questions for the care team

• How much fiber is currently coming from food rather than supplements?
• Is there any bowel condition that makes rapid fiber escalation unsafe?
• Are probiotic supplements being used, and does the oncology team know?

Funding and conflicts

The work had government, foundation and institutional support. Several investigators disclosed microbiome-related patents. Published December 23, 2021.

Sources

• Human cohort and preclinical study (PMID 34941392)
• Full text (PMCID PMC8970537)
• NCI research summary
• DOI 10.1126/science.aaz7015

Last literature search: 27 October 2026. Record appraisal: 27 October 2026. This page is educational and does not replace individualized medical advice. Symptom, biomarker, immune-marker or nutritional changes must not be interpreted as proof of tumor control, recurrence prevention or longer survival unless those outcomes were directly tested.